Charles River Microbial Solutions

Trending Articles

  1. NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant...
  2. Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Delivering precision: why advanced therapies are redefining pharmaceutical logistics As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael...
  4. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic...
  5. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery...

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

Related Content

Research & Development

Charles River joins EASYGEN Consortium to advance bedside CAR-T cell therapy manufacturing

The Consortium aims to develop a fully automated, hospital-based platform that's capable of manufacturing personalised cell therapies in 24 hours
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Viral clearance in 2025: navigating complexity with strategy and science

Ensuring the safety of products derived from human or animal origin, viral clearance (VC) remains a cornerstone of biologics manufacturing
Finance

Charles River and BioTech Social pursue crowdfunding partnership

Aim to enhance Charles River incubator and accelerator programmes by adding crowdfunding features, aiding early stage developers
Training & Education

Charles River Laboratories names Advanced Therapy Incubator Programme cohort

The programme is designed to support early-stage biotech companies in getting their biologic or cell & gene therapy products and technologies to market
Research & Development

FairJourney Biologics acquires Charles River's US antibody discovery site

The antibody discovery and engineering site in South San Francisco, US will expand FairJourney's reach in the key North American market, while positioning the company in one of the world's largest biotech clusters

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Picking a CDMO as a CGT developer: what to consider and why

Cell and gene therapy development and manufacture can be risky and highly complex, so biopharma companies would benefit from investing in a reliable and experienced CDMO
Subscribe now